NO20063393L - Farmasoytiske preparater - Google Patents
Farmasoytiske preparaterInfo
- Publication number
- NO20063393L NO20063393L NO20063393A NO20063393A NO20063393L NO 20063393 L NO20063393 L NO 20063393L NO 20063393 A NO20063393 A NO 20063393A NO 20063393 A NO20063393 A NO 20063393A NO 20063393 L NO20063393 L NO 20063393L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical preparations
- antagonists
- disclosed
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4747—Quinolines; Isoquinolines spiro-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53173503P | 2003-12-22 | 2003-12-22 | |
| PCT/US2004/042893 WO2005063243A1 (fr) | 2003-12-22 | 2004-12-20 | Compositions pharmaceutiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20063393L true NO20063393L (no) | 2006-07-21 |
Family
ID=34738689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20063393A NO20063393L (no) | 2003-12-22 | 2006-07-21 | Farmasoytiske preparater |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20050153999A1 (fr) |
| EP (1) | EP1706116A1 (fr) |
| JP (1) | JP2007515425A (fr) |
| KR (1) | KR20060113737A (fr) |
| CN (1) | CN1897942A (fr) |
| AR (1) | AR046769A1 (fr) |
| AU (1) | AU2004308935A1 (fr) |
| BR (1) | BRPI0417950A (fr) |
| CA (1) | CA2550432A1 (fr) |
| MX (1) | MXPA06007210A (fr) |
| NO (1) | NO20063393L (fr) |
| PE (1) | PE20051049A1 (fr) |
| PL (1) | PL380482A1 (fr) |
| TW (1) | TW200531686A (fr) |
| WO (1) | WO2005063243A1 (fr) |
| ZA (1) | ZA200605080B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5352446B2 (ja) * | 2006-04-05 | 2013-11-27 | オプコ ヘルス， インコーポレイテッド | ８−［｛１−（３，５−ビス−（トリフルオロメチル）フェニル）−エトキシ｝−メチル］−８−フェニル−１，７−ジアザ−スピロ［４．５］デカン−２−オンの塩酸塩およびその調製プロセス |
| AR060352A1 (es) * | 2006-04-05 | 2008-06-11 | Schering Corp | Sales de 8- [(1- (3,5-bis- (trifluorometil) fenil) -etoxi) -metil] -8-fenil-1,7 -diaza- espiro [4.5] decan -2-ona y proceso de preparacion de las mismas |
| AU2007233389C1 (en) | 2006-04-05 | 2013-07-25 | Opko Health, Inc. | Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| PE20081891A1 (es) * | 2007-03-22 | 2008-12-27 | Opko Health Inc | Formulaciones de comprimidos que contienen sales de 8-[{1-(3,5-bis-(trifluorometil)fenil)-etoxi}-metil]-8-fenil-1,7-diaza-spiro[4.5]decan-2-ona y comprimidos elaborados a partir de estas |
| AR066191A1 (es) * | 2007-03-22 | 2009-08-05 | Schering Corp | Proceso e intermediarios para la sintesis de compuestos 8- [ ( 1- (3,5- bis- ( trifluorometil) fenil) - etoxi ) - metil]- 8 fenil - 1,7- diaza - espiro (4, 5) decan -2 ona |
| EP2370439A1 (fr) * | 2008-11-23 | 2011-10-05 | Pfizer Inc. | Lactames en tant qu'inhibiteurs de bêta-sécrétase |
| AU2014271269B2 (en) * | 2009-08-14 | 2016-11-03 | Opko Health, Inc. | Intravenous formulations of neurokinin-1 antagonists |
| RU2017145628A (ru) * | 2009-08-14 | 2019-02-19 | ОПКО Хельс, Инк. | Композиции антагонистов нейрокинина-1 для внутривенного введения |
| RU2019104004A (ru) * | 2012-01-23 | 2019-03-07 | Сейдж Терапьютикс, Инк. | Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс |
| NL2018041B1 (en) * | 2016-12-22 | 2018-06-28 | Land Life Company B V | Process to prepare a biodegradable pulp product |
| WO2020232274A1 (fr) * | 2019-05-15 | 2020-11-19 | Bexson Biomedical, Inc. | Formulation de kétamine pour injection sous-cutanée |
| WO2020259675A1 (fr) | 2019-06-28 | 2020-12-30 | 上海盛迪医药有限公司 | Antagoniste de neurokinine-1 |
| JP2023519570A (ja) | 2020-04-03 | 2023-05-11 | ネッレ セラピューティクス リミテッド | 新規使用 |
| BR112022024208A2 (pt) | 2020-06-02 | 2022-12-20 | Nerre Therapeutics Ltd | Antagonistas do receptor de neurocinina (nk)-1 para uso no tratamento de condições de fibrose pulmonar promovidas por lesão mecânica aos pulmões |
| CA3198795A1 (fr) | 2020-11-18 | 2022-05-27 | Jeffrey Becker | Formulations salines de composes pharmaceutiques a base d'agents complexants |
| CN116472048B (zh) * | 2020-12-25 | 2025-02-18 | 上海盛迪医药有限公司 | Nk1拮抗剂前药化合物与5-ht3受体拮抗剂的联用用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2791346B3 (fr) * | 1999-03-25 | 2001-04-27 | Sanofi Sa | Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant |
| AU2002254309B2 (en) * | 2001-03-20 | 2006-02-02 | Cydex, Inc. | Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| PE20030762A1 (es) * | 2001-12-18 | 2003-09-05 | Schering Corp | Compuestos heterociclicos como antagonistas nk1 |
-
2004
- 2004-12-20 WO PCT/US2004/042893 patent/WO2005063243A1/fr not_active Ceased
- 2004-12-20 KR KR1020067012300A patent/KR20060113737A/ko not_active Withdrawn
- 2004-12-20 JP JP2006545570A patent/JP2007515425A/ja not_active Withdrawn
- 2004-12-20 AU AU2004308935A patent/AU2004308935A1/en not_active Abandoned
- 2004-12-20 MX MXPA06007210A patent/MXPA06007210A/es not_active Application Discontinuation
- 2004-12-20 AR ARP040104804A patent/AR046769A1/es not_active Application Discontinuation
- 2004-12-20 TW TW093139690A patent/TW200531686A/zh unknown
- 2004-12-20 CA CA002550432A patent/CA2550432A1/fr not_active Abandoned
- 2004-12-20 BR BRPI0417950-1A patent/BRPI0417950A/pt not_active Application Discontinuation
- 2004-12-20 EP EP04815019A patent/EP1706116A1/fr not_active Withdrawn
- 2004-12-20 CN CNA200480038273XA patent/CN1897942A/zh active Pending
- 2004-12-20 US US11/017,156 patent/US20050153999A1/en not_active Abandoned
- 2004-12-20 PL PL380482A patent/PL380482A1/pl not_active Application Discontinuation
-
2005
- 2005-01-03 PE PE2005000022A patent/PE20051049A1/es not_active Application Discontinuation
-
2006
- 2006-06-20 ZA ZA200605080A patent/ZA200605080B/xx unknown
- 2006-07-21 NO NO20063393A patent/NO20063393L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PE20051049A1 (es) | 2006-01-03 |
| KR20060113737A (ko) | 2006-11-02 |
| JP2007515425A (ja) | 2007-06-14 |
| ZA200605080B (en) | 2008-06-25 |
| AU2004308935A1 (en) | 2005-07-14 |
| MXPA06007210A (es) | 2006-08-18 |
| BRPI0417950A (pt) | 2007-04-17 |
| WO2005063243A1 (fr) | 2005-07-14 |
| CN1897942A (zh) | 2007-01-17 |
| PL380482A1 (pl) | 2007-02-05 |
| EP1706116A1 (fr) | 2006-10-04 |
| US20050153999A1 (en) | 2005-07-14 |
| CA2550432A1 (fr) | 2005-07-14 |
| AR046769A1 (es) | 2005-12-21 |
| TW200531686A (en) | 2005-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052739D0 (no) | CCR5-antagonister som medikamenter | |
| NO20052493D0 (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
| NO20042807L (no) | Farmasoytiske sammensetninger som innbefatter aktive vitamin D forbindelser | |
| HRP20080564T3 (hr) | Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže | |
| NO20052306D0 (no) | Dispergerbare farmasoytiske blandinger. | |
| BRPI0417717A (pt) | composto, composição farmacêutica, e, uso de um composto | |
| DK1592457T3 (da) | Folat-vinblastin-konjugat som lægemiddel | |
| CY1108547T1 (el) | Αναλογα σωματοστατινης | |
| KR20050009999A (ko) | 약제학적 제제 | |
| DK1397364T3 (da) | Hidtil ukendte pyrrolderivater som farmaceutiske midler | |
| DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
| LTC1608344I2 (lt) | Per burną vartojamos kladribino kompozicijos | |
| NO20063393L (no) | Farmasoytiske preparater | |
| SE0301653D0 (sv) | Novel compounds | |
| PL375874A1 (pl) | Wodne kompozycje farmaceutyczne 2,6-diizopropylofenolu | |
| IS7051A (is) | Lyfjasamsetningar | |
| NO20052952D0 (no) | Farmasoytisk sammensetning som innbefatter mikropartikler | |
| DE60316954D1 (de) | Shampoozusammensetzungen | |
| DK1648882T3 (da) | 3-fluor-piperidiner som NMDA/NR2B-antagonister | |
| BRPI0417205A (pt) | composições farmacêuticas | |
| NO995945L (no) | Nye forbindelser | |
| TNSN06012A1 (en) | Emulsifying systems containing azetidine derivatives | |
| EA200501565A1 (ru) | Предназначенная для перорального приёма лекарственная форма для антагонистов протонного насоса | |
| EE200300465A (et) | Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid | |
| NO20044164L (no) | Farmasoytiske sammensetninger |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |